Walgreens

Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross domestic product. McKinsey & Co. follows suit, noting AI could generate 30% efficiency gains and cost savings in the pharmaceutical sector and trigger financial gains of up to $110 billion annually.

Welldoc ®, a digital health leader revolutionizing cardiometabolic care, today announced that it has been named a winner in the 2025 Artificial Intelligence Excellence Awards program presented by the Business Intelligence Group.

Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases offering training for it.

Home Depot uses generative AI for customer questions; Pinterest experiments with labeling technology to address AI content flood and more.

Wipro GE Healthcare has unveiled the Versana Premier R3, an advanced ultrasound system integrating artificial intelligence to enhance diagnostic accuracy and streamline clinical workflows. This state-of-the-art device aligns with the 'Make in India' initiative,

Aldi says it will be able to expedite the delivery of customer-focused product information on its website, app, and email. This story was originally published on Supermarketnews. Aldi is partnering with tech company Digital Wave Technology to use an AI tool that is supposed to boost automation on digital channel product descriptions.

Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare industry. Just last month, AWS and General Catalyst announced their partnership to speed up the development and deployment of healthcare AI tools.

We recently published a list of 35 Non-Tech AI Opportunities Amid DeepSeek Selloff. In this article, we are going to take a look at where IQVIA Holdings Inc. (NYSE:IQV) stands against other non-tech AI opportunities amid DeepSeek selloff.